Short Daily-Life Walking Bouts and Poor Self-Reported Health Predict the Onset of Depression in Community-Dwelling Older People: A 2-Year Longitudinal Cohort Study

This study aimed to assess whether the amount and quality of daily-life walking obtained using wearable technology can predict depression onset over a 2-year period, independently of self-reported health status.

Longitudinal cohort study.

Three-hundred twenty-two community-dwelling older people recruited in Sydney, Australia.

Participants were assessed at baseline on (1) depressive symptoms using the Patient Health Questionnaire-9; (2) average weekly physical activity levels over the past month using the Incidental and Planned Activity Questionnaire, (3) clinical mobility tests (ie, short physical performance battery, timed up-and-go test, 6-m walk test); and (4) amount and quality of daily-life walking assessed with a trunk accelerometer (MoveMonitor, McRoberts) for 1 week. Participants were followed up for onset of depressive symptoms for 2 years at 6-monthly intervals.

Daily-life walking (ie, gait intensity in the mediolateral axis, daily step counts, duration of longest walk) and self-rated health predicted the new onset of depressive symptoms at 2 years in univariable logistic regression models. In multivariable models containing a self-rated health measure, clinical mobility tests were not predictive of the onset of depressive symptoms. In contrast, a measure of daily-life walking (duration of longest walking bout) was identified as a significant predictor of depressive symptom onset [standardized odds ratio (SOR) 2.44, 95% CI 1.62-3.76] independent of self-rated health (SOR 1.51, 95% CI 1.16-1.96), with these 2 measures achieving a satisfactory prediction accuracy (area under the curve = 0.67, sensitivity: 0.78, specificity: 0.52).

A risk algorithm based on daily-life walking bouts and self-reported health demonstrated good accuracy for the prediction of depression onset in older people over 2 years. Wearable sensor data compared favorably with clinical mobility screens and may add important independent information for screening for depression among older people.